Most Recent
Maurice Blackburn faces referee over fees in QBE class action
A judge has called for a referee to look at Maurice Blackburn's fees for running a shareholder class action against QBE Insurance that settled late last year for $133 million. 
Reckitt Benckiser sues P&G over TV commercial
Reckitt Benckiser has brought a claim against its familiar courtroom foe - consumer goods giant Procter & Gamble - over a television commercial and in-store promotion it says violates the consumer laws.
Lawyer to square off against IP Australia over software patent
Patent lawyer and inventor Todd Martin will get two days in court to challenge the Australian Patent Office's decision to reject his innovation for failing the manner of manufacture test, one of two closely watched appeals challenging computer software patent rejections.
Ex-Norton Rose partner can’t move mediation out of Sydney
A former Norton Rose employment partner in litigation with the firm over his firing has lost his bid to move next week's scheduled mediation out of Sydney.
AstraZeneca resolves Crestor patent spat with Generic Health
Pharmaceutical companies AstraZeneca and Generic Health have laid down their swords in a long-running patent dispute over AstraZeneca's cholesterol drug Crestor, two-and-a-half years after the High Court of Australia found the patent obvious and invalid.
Shine confident it can defend shareholder class action
Publicly traded law firm Shine Lawyers has assured investors it can wage a successful defence against a $250 million class action claiming the firm misled shareholders about the value of ongoing business activities.
Online course stole US company’s copyright, judge says
A judge ruled Wednesday that online educator TalentMed violated the copyright of educational materials prep company Career Step when it "cut corners" and lifted text to create a competing course.
Reckitt Benckiser to feel pain of GSK’s costs in Nurofen case
Reckitt Benckiser has been ordered to pay all of GlaxoSmithKline's legal bill after a judge found the drug giant misled consumers with claims that Nurofen was a more effective pain killer than its rival's Panadol.
ACCC ready to tackle competition in finance sector
The Australian Competition and Consumer Commission said it is well positioned to investigate competition in the financial sector, in response to a recent report calling for a dedicated financial services competition regulator.
Takata airbag class actions to balloon following mandatory recall
The class actions against car companies over defective Takata airbags are expected to dramatically grow after the first-of-its-kind mandatory recall announced by the government Wednesday.